Clinical Trial Update: Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in Non-Hodgkin lymphoma evaluating autologous followed by non-myeloablative allogeneic transplantation; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: TERMINATED | Results posted: 2018-02-14